Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 129

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Etoposide Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma

Huimei Guo, Jia Liu, Hua Xue, Songying Zhao, Jing Wang, Jianmei Xu, Jiangbo Zhang, Yao Liu

Blood (2024) 144 (Supplement 1): 2099.

https://doi.org/10.1182/blood-2024-204326

Published: 2024

Journal Articles

Genetic Abnormalities Associated with Outcomes in Unfit Patients with Acute Myeloid Leukemia Receiving Less Intensive Therapy in the Real World

Lu Yu, Lijuan Hu, Zongru Li, Ting Zhao, Wenbing Duan, Jing Wang, JinSong Jia, Jing Liu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, LanPing Xu, Yu Wang, Xiaojun Huang, Qian Jiang

Blood (2024) 144 (Supplement 1): 1537.

https://doi.org/10.1182/blood-2024-207269

Published: 2024

Journal Articles

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5845.

https://doi.org/10.1182/blood-2024-205492

Published: 2024

Journal Articles

Interim Analysis of Dara VRD in the Treatment of TE-NDMM Patients with Standard Risk Who Refused to Accept ASCT As First Line in China

Chengcheng Fu, Jing Wang, Song Jin, Lingzhi Yan, Jingjing Shang, Weiqin Yao, Xiaolan Shi, Zhi Yan, Depei Wu

Blood (2024) 144 (Supplement 1): 1997.

https://doi.org/10.1182/blood-2024-209260

Published: 2024

Journal Articles

The Significance and Predictive Performance of Gait Speed and Grip Strength in Frailty Assessment of Newly Diagnosed DLBCL

Hua Xue, Jiangbo Zhang, Jing Wang, Songying Zhao, Huimei Guo, Jia Liu, Jianmei Xu, Yao Liu

Blood (2024) 144 (Supplement 1): 6459.

https://doi.org/10.1182/blood-2024-202228

Published: 2024

Journal Articles

Exploring Droplet Digtial PCR Detection of MYD88 L265P mutation Burden for the Evaluation of Efficacy in Patients with WM : A Convenient and Accurate Supplementary Approach to IMWG-11 Criteria

Hua Xue, Wenjie Li, Songying Zhao, Jing Wang, Huimei Guo, Jia Liu, Jiangbo Zhang, Jianmei Xu, Yao Liu

Blood (2024) 144 (Supplement 1): 6330.

https://doi.org/10.1182/blood-2024-202497

Published: 2024

Journal Articles

Prognostic Significance of POD24 and Monoclonal Paraproteinemia in Extranodal MZL

Lingli Wang, Jinjie Gao, Wei Wan, Fei Dong, Jing Wang, Weilong Zhang, Ping Yang, Lan Ma, Wei Zhao, Jijun Wang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6340.

https://doi.org/10.1182/blood-2024-205570

Published: 2024

Journal Articles

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Ping Yang, Chunyuan Li, Jinjie Gao, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6339.

https://doi.org/10.1182/blood-2024-205068

Published: 2024

Journal Articles

Treatment Outcomes of BTK Inhibitors and Venetoclax with/without Anti-CD20 Monoclonal Antibody in Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Real-World Experience

Ping Yang, Chunyuan Li, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6338.

https://doi.org/10.1182/blood-2024-205042

Published: 2024

Journal Articles

Central Nervous System Involvement in Mantle Cell Lymphoma: Clinical Features, Prognostic Factors and Outcomes from Multi-Centers in China

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Weilong Zhang, Jing Wang, Yingtong Chen, Xiaoyu Hao, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6337.

https://doi.org/10.1182/blood-2024-204938

Published: 2024

Journal Articles

Favorable Outcomes in Pediatric R/R-ALL Following Immunotherapy with CAR-T and UCB Combined to TCR αβ -Depleted Haplo-HSCT

Huaying Liu, Dejun Chen, Jing Wang, Simeng Lv, Yuelin He, Wing Leung, Chunfu Li

Blood (2024) 144 (Supplement 1): 4941.

https://doi.org/10.1182/blood-2024-205593

Published: 2024

Journal Articles

A New Frailty Assessment Model Incorporating Gait Speed and Grip Strength for Multiple Myeloma and Consistency Analysis with IMWG-FI

Hua Xue, Yan Su, Jianmei Xu, Jiangbo Zhang, Songying Zhao, Jing Wang, Huimei Guo, Jia Liu, Yao Liu

Blood (2024) 144 (Supplement 1): 3759.

https://doi.org/10.1182/blood-2024-206921

Published: 2024

Journal Articles

Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China

Zongru Li, Lu Yu, Li-Juan Hu, Ting Zhao, Wenbing Duan, Jing Wang, Jinsong Jia, Jing Liu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, Lanping Xu, Yu Wang, Xiaojun Huang, Qian Jiang

Blood (2024) 144 (Supplement 1): 6121.

https://doi.org/10.1182/blood-2024-211874

Published: 2024

Journal Articles

Clinical Analysis of Multiple Myeloma with Spinal Cord Compression Due to EMD-B: Experience from a Single Center

Hua Xue, Shuai Li, Jianmei Xu, Jiangbo Zhang, Jing Wang, Songying Zhao, Huimei Guo, Jia Liu, Yao Liu

Blood (2024) 144 (Supplement 1): 7837.

https://doi.org/10.1182/blood-2024-206947

Published: 2024

Journal Articles

Therapeutic Efficacy Analysis of 16 Patients with Primary Systemic Light Chain Amyloidosis Predominantly Exhibiting Advanced Cardiac Amyloidosis

Hua Xue, Jing Wang, Shaojie Ye, Huimei Guo, Songying Zhao, Jia Liu, Jiangbo Zhang, Jianmei Xu, Yao Liu

Blood (2024) 144 (Supplement 1): 7830.

https://doi.org/10.1182/blood-2024-204139

Published: 2024

Journal Articles

The Well Tolerated VA-Based Regimen Bringing to High Quality of Life Did Not Absolutely Inferior to Intensive Chemotherapy in AML Patients with NPM1 Mutation

Wenbing Duan, Qi Chen, WenJing Yu, Jinsong Jia, Jing Wang, Xiaolu Zhu, Ting Zhao, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Hongxia Shi, Ying-Jun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang

Blood (2024) 144 (Supplement 1): 5952.

https://doi.org/10.1182/blood-2024-206400

Published: 2024

Journal Articles

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Combined with Etoposide and Cytarabine in the Treatment of Newly Diagnosed Acute Myelomonocytic Leukemia or Acute Monocytic Leukemia

Hua Xue, Huimei Guo, Shaojie Ye, Jing Wang, Songying Zhao, Jianmei Xu, Jiangbo Zhang, Jia Liu, Yao Liu

Blood (2024) 144 (Supplement 1): 6033.

https://doi.org/10.1182/blood-2024-201895

Published: 2024

Journal Articles

Targeting p53 Improves Drug Resistance in Mantle Cell Lymphoma By Regulating Mitophagy-Dependent Ferroptosis

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5836.

https://doi.org/10.1182/blood-2024-205447

Published: 2024

Journal Articles

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Ping Yang, Chunyuan Li, Shuozi Liu, Yuan Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6305.

https://doi.org/10.1182/blood-2024-205002

Published: 2024

Journal Articles

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6303.

https://doi.org/10.1182/blood-2024-204939

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Safety and Efficacy of Etoposide Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma

Genetic Abnormalities Associated with Outcomes in Unfit Patients with Acute Myeloid Leukemia Receiving Less Intensive Therapy in the Real World

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Interim Analysis of Dara VRD in the Treatment of TE-NDMM Patients with Standard Risk Who Refused to Accept ASCT As First Line in China

The Significance and Predictive Performance of Gait Speed and Grip Strength in Frailty Assessment of Newly Diagnosed DLBCL

Exploring Droplet Digtial PCR Detection of MYD88 L265P mutation Burden for the Evaluation of Efficacy in Patients with WM : A Convenient and Accurate Supplementary Approach to IMWG-11 Criteria

Prognostic Significance of POD24 and Monoclonal Paraproteinemia in Extranodal MZL

Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)

Treatment Outcomes of BTK Inhibitors and Venetoclax with/without Anti-CD20 Monoclonal Antibody in Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Real-World Experience

Central Nervous System Involvement in Mantle Cell Lymphoma: Clinical Features, Prognostic Factors and Outcomes from Multi-Centers in China

Favorable Outcomes in Pediatric R/R-ALL Following Immunotherapy with CAR-T and UCB Combined to TCR αβ -Depleted Haplo-HSCT

A New Frailty Assessment Model Incorporating Gait Speed and Grip Strength for Multiple Myeloma and Consistency Analysis with IMWG-FI

Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China

Clinical Analysis of Multiple Myeloma with Spinal Cord Compression Due to EMD-B: Experience from a Single Center

Therapeutic Efficacy Analysis of 16 Patients with Primary Systemic Light Chain Amyloidosis Predominantly Exhibiting Advanced Cardiac Amyloidosis

The Well Tolerated VA-Based Regimen Bringing to High Quality of Life Did Not Absolutely Inferior to Intensive Chemotherapy in AML Patients with NPM1 Mutation

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Combined with Etoposide and Cytarabine in the Treatment of Newly Diagnosed Acute Myelomonocytic Leukemia or Acute Monocytic Leukemia

Targeting p53 Improves Drug Resistance in Mantle Cell Lymphoma By Regulating Mitophagy-Dependent Ferroptosis

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only